Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

89.97 -3.77 (-4.02%)
Streaming Delayed Price Updated: 3:38 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Why Boston Scientific (BSX) Stock Is Down Today
Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the company agreed to acquire Penumbra in a transaction valued at approximately $14.5 billion,... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence
Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement? ↗
Via Stocktwits
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)
From Brodsky & Smith LLC
Via GlobeNewswire
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Medtronic (MDT) Deep-Dive: Can the MedTech Giant Outpace the Market in 2026?
Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical... 
Via PredictStreet
Topics Artificial Intelligence Economy Product Recall
News headline image
2 Growth Stocks to Add to Your Roster and 1 We Find Risky
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has... 
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
Earnings Renaissance: Why 2026 Profit Projections are Propping Up Record Valuations
As 2025 draws to a close, the financial markets are entering the new year with a sense of cautious exuberance. Despite a year of navigating fluctuating interest rates and geopolitical tensions, the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗
This basket of 64 medical device stocks could raise its dividend for decades. 
Via The Motley Fool
Topics ETFs Government Supply Chain
News headline image
1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
2 Profitable Stocks to Consider Right Now and 1 We Turn Down
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Supply Chain
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
News headline image
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
2 Reasons to Watch BSX and 1 to Stay Cautious
Boston Scientific has been treading water for the past six months, recording a small loss of 3.5% while holding steady at $102.88. The stock also fell short of the S&P 500’s 13% gain during that... 
Via StockStory
Topics Stocks
News headline image
3 Market-Beating Stocks with Solid Fundamentals
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
News headline image
1 High-Flying Stock with Promising Prospects and 2 That Underwhelm
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Electric Vehicles
News headline image
A Look Into Boston Scientific Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Boston Scientific Corp (NYSE:BSX) Shows Strong Growth and Bullish Technical Setup ↗
Discover Boston Scientific (BSX), a top growth stock with strong earnings, revenue acceleration, and a bullish technical setup signaling a potential price surge. 
Via Chartmill
News headline image
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
News headline image
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call
Boston Scientific’s third quarter saw a positive market reaction, reflecting operational execution across multiple business units. Management attributed the strong results to broad-based growth,... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.